Curis (CRIS) director receives grant of 6,800 non-qualified stock options

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CURIS INC director Kenneth I. Kaitin reported receiving a grant of non-qualified stock options linked to the company’s common stock. The award covers 6,800 options with an exercise price of $5.29 per share, giving the right to acquire 6,800 shares of common stock.

The options vest as to 100% of the underlying shares on July 7, 2027 and carry an expiration date of July 6, 2036. Following this grant, the filing shows 6,800 derivative securities held directly, reflecting a routine compensation-related equity award rather than an open-market stock purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KAITIN KENNETH I

Role null

Type	Security	Shares	Price	Value
Grant/Award	Non Qualified Stock Option	6,800	$5.29	$36K

Holdings After Transaction: Non Qualified Stock Option — 6,800 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Options granted: 6,800 options Exercise price: $5.29 per share Underlying shares: 6,800 shares +3 more

6 metrics

Options granted 6,800 options Non-qualified stock option grant to director

Exercise price $5.29 per share Non-qualified stock option strike price

Underlying shares 6,800 shares Common stock underlying the option grant

Vesting date July 7, 2027 100% of underlying shares vest on this date

Expiration date July 6, 2036 Option grant expiration if unexercised

Post-transaction derivatives 6,800 derivative securities Total options held directly after grant

Key Terms

Non Qualified Stock Option, grant/award acquisition, derivative securities, vests as to 100% of the underlying shares, +1 more

5 terms

Non Qualified Stock Option financial

"security_title: "Non Qualified Stock Option""

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

derivative securities financial

"total_shares_following_transaction shows 6,800 derivative securities held"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

vests as to 100% of the underlying shares financial

"footnote states the option grant vests as to 100% of the underlying shares"

expiration date financial

"expiration_date is listed as 2036-07-06 for the option grant"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/09/2026 - 04:12 PM Accepted by SEC EDGAR 07/09/2026 - 04:12 PM

FAQ

What insider transaction did CURIS INC (CRIS) report for Kenneth I. Kaitin?

CURIS INC reported that director Kenneth I. Kaitin received a grant of 6,800 non-qualified stock options. These options relate to the company’s common stock and were reported on Form 4 as a compensation-type grant rather than an open-market share purchase or sale.

How many CURIS INC (CRIS) options were granted to Kenneth I. Kaitin and at what price?

Kenneth I. Kaitin was granted 6,800 non-qualified stock options with an exercise price of $5.29 per share. Each option corresponds to one share of CURIS INC common stock, giving him rights to acquire up to 6,800 shares at that fixed exercise price.

When do Kenneth I. Kaitin’s CURIS INC (CRIS) stock options vest and expire?

The stock options granted to Kenneth I. Kaitin vest as to 100% of the underlying shares on July 7, 2027. According to the filing footnote, these non-qualified stock options carry an expiration date of July 6, 2036, if not earlier exercised or forfeited.

Is Kenneth I. Kaitin’s CURIS INC (CRIS) Form 4 transaction a market buy or sell?

The Form 4 describes the transaction as a grant or award acquisition of derivative securities, coded as an “A” transaction. This indicates a compensation-related option grant, not an open-market purchase or sale of CURIS INC common stock by the director.

How many CURIS INC (CRIS) derivative securities does Kenneth I. Kaitin hold after this grant?

After this reported grant, Kenneth I. Kaitin holds 6,800 derivative securities directly, according to the Form 4. These represent the newly granted non-qualified stock options tied to CURIS INC common stock, with no additional derivative positions listed in the derivative summary.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KAITIN KENNETH I

(Last)

(First)

(Middle)

128 SPRING STREET

BUILDING C - SUITE 500

(Street)

LEXINGTON

MASSACHUSETTS

02421

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURIS INC [ CRIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non Qualified Stock Option	$5.29	07/07/2026		A		6,800		⁽¹⁾	07/06/2036	Common Stock	6,800	$5.29	6,800	D

Explanation of Responses:

1. The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027.

Remarks:

Exhibit Index: 24.1 Power of Attorney

	/s/ Diantha Duvall, Attorney-in-fact	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR